Metabolomics and preterm birth: What biomarkers in cervicovaginal secretions are predictive of high-risk pregnant women?

International Journal of Mass Spectrometry

Volumn 307, Issue 1-3, 2011, Pages 33-38

  Auray Blais, Christiane ^a   Raiche, Evelyne ^a   Gagnon, René ^a   Berthiaume, Maryse ^a   Pasquier, Jean Charles ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Biomarkers; Cervicovaginal secretions; Metabolomics; Preterm birth; Time of flight mass spectrometry

Indexed keywords

EID: 80052961525     PISSN: 13873806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijms.2011.02.009     Document Type: Article

References (14)

1. R.L. Goldenberg, J.F. Culhane, J.D. Iams, and R. Romero Preterm birth 1. Epidemiology and causes of preterm birth The Lancet 371 9606 2008 75 84
2. World Health Organization (WHO) Global Program to Conquer Preeclampsia/Eclampsia 2002 http://www.preeclampsia.org/statistics.asp
3. W.M. Gilbert, T.S. Nesbitt, and B. Danielsen The cost of prematurity: quantification by gestational age and birth weight Obstet. Gynecol. 102 3 2003 488 492 (Pubitemid 37311208)
4. M.T. Mella, and V. Berghella Prediction of preterm birth: cervical sonography Semin. Perinatol. 33 5 2009 317 324
5. M. Van den Hof, and J. Crane Ultrasound cervical assessment in predicting preterm birth J. SOGC 102 2001 1 4
6. S.Q. Wei, W. Fraser, and Z.C. Luo Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review Obstet. Gynecol. 116 2 Pt 1 2010 393 401
7. O. Fiehn, B. Kristal, B. van Ommen, L.W. Sumner, S.A. Sansone, C. Taylor, N. Hardy, and R. Kaddurah-Daouk Establishing reporting standards for metabolomic and metabonomic studies: a call for participation OMICS 10 2 2006 158 163 (Pubitemid 44298603)
8. R.P. Horgan, O.H. Clancy, J.E. Myers, and P.N. Baker An overview of proteomic and metabolomic technologies and their application to pregnancy research BJOG 116 2009 173 181
9. M. Mamas, W.B. Dunn, L. Neyses, and R. Goodacre The role of metabolites and metabolomics in clinically applicable biomarkers of disease Arch. Toxicol. 85 1 2011 5 17
10. J.D. Stewart, and H.M. Bolt Metabolomics: biomarkers of disease and drug toxicity Arch. Toxicol. 85 1 2011 3 4
11. C. Auray-Blais, C.R. Gagnon, J.T.R. Clarke, S.P. Young, and D.S. Millington Metabolomics, biomarker discovery and Fabry disease: an efficient platform is necessary! Clin. Therapeut. 31 2009 S24 S25
12. G.D. Lewis, A. Asnani, and R.E. Gerszten Application of metabolomics to cardiovascular biomarker and pathway discovery J. Am. Coll. Cardiol. 52 2 2008 117 123 (Pubitemid 351885452)
13. R. Romero, S. Mazaki-Tovi, E. Vaisbuch, J.P. Kusanovic, T. Chaiworapongsa, R. Gomez, J.K. Nien, B.H. Yoon, M. Mazor, J. Luo, D. Banks, J. Ryals, and C. Beecher Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery J. Matern. Fetal Neonatal. Med. 23 12 2010 1344 1359
14. E. Raiche, A. Ouellet, J. Poulin, M. Berthiaume, E. Rousseau, and J.-C. Pasquier Prediction of preterm delivery by supracervical and cervical ultrasound assessment associated with detection of vaginal inflammation (Colibri study) Am. J. Obs. Gyn. Suppl. 2009 S192